73 related articles for article (PubMed ID: 9421248)
21. [On the use of dimethazine in fibrocystic dysplasia].
Mastrorilli A
Minerva Ortop; 1966 Jun; 17(6):341-4. PubMed ID: 5963965
[No Abstract] [Full Text] [Related]
22. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
[TBL] [Abstract][Full Text] [Related]
23. How do bone resorption inhibitors increase bone mineral density?
Boivin G; Meunier PJ
Rev Rhum Engl Ed; 1999 Nov; 66(11):534-7. PubMed ID: 10591113
[No Abstract] [Full Text] [Related]
24. Denosumab for Fibrous Dysplasia: Promising, but Questions Remain.
Collins MT; de Castro LF; Boyce AM
J Clin Endocrinol Metab; 2020 Nov; 105(11):e4179-80. PubMed ID: 32478399
[No Abstract] [Full Text] [Related]
25. Alendronate in postmenopausal osteoporosis.
McGrath H
N Engl J Med; 1996 Mar; 334(11):734; author reply 734-5. PubMed ID: 8594443
[No Abstract] [Full Text] [Related]
26. Effective analgesia with tramadol for osteofibrous dysplasia refractory to NSAID medication.
Weingarten TN; Hooten WM; Obray JB
J Orthop Res; 2005 Nov; 23(6):1495; author reply 1496. PubMed ID: 16005174
[No Abstract] [Full Text] [Related]
27. [Osteoporosis in patients under treatment for cancer and the possibilities for prevention and treatment].
Eekhoff EM; Pinedo HM; Lips P
Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1388-93. PubMed ID: 17668601
[TBL] [Abstract][Full Text] [Related]
28. [Albright's syndrome treated with calcitonin].
Dragović M; Vidaković B; Plećas V
Srp Arh Celok Lek; 1976; 104(11-12):913-9. PubMed ID: 1030537
[No Abstract] [Full Text] [Related]
29. Bisphosphonate therapy for osteoporosis.
Attie MF
Hosp Pract (Off Ed); 1991 Mar; 26(3A):87-90. PubMed ID: 1900862
[No Abstract] [Full Text] [Related]
30. Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
Voskaridou E; Christoulas D; Antoniadou L; Terpos E
Acta Haematol; 2008; 119(1):40-4. PubMed ID: 18253025
[No Abstract] [Full Text] [Related]
31. Bisphosphonates and glucocorticoids: effects on bone quality.
Lems WF
Arthritis Rheum; 2007 Nov; 56(11):3518-22. PubMed ID: 17968935
[No Abstract] [Full Text] [Related]
32. [Bisphosphonate, a new therapy principle in diseases of bone metabolism].
Raue F; Grauer A
Med Klin (Munich); 1994 Aug; 89(8):421-8. PubMed ID: 7968875
[No Abstract] [Full Text] [Related]
33. [Osteoporosis therapy in general practice. Which measure should be included?].
Abendroth K
MMW Fortschr Med; 2002 Oct; 144(42):62. PubMed ID: 12534001
[No Abstract] [Full Text] [Related]
34. Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial.
Voskaridou E; Christoulas D; Konstantinidou M; Tsiftsakis E; Alexakos P; Terpos E
Haematologica; 2008 Oct; 93(10):1588-90. PubMed ID: 18698086
[No Abstract] [Full Text] [Related]
35. Do not use bisphosphonate therapy indefinitely for fracture prevention.
Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
[TBL] [Abstract][Full Text] [Related]
36. Are drugs helpful in adults with osteogenesis imperfecta?
Chevrel G; Meunier PJ
Rev Rhum Engl Ed; 1997 May; 64(5):283-6. PubMed ID: 9190000
[No Abstract] [Full Text] [Related]
37. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).
Nawata H; Soen S; Takayanagi R; Tanaka I; Takaoka K; Fukunaga M; Matsumoto T; Suzuki Y; Tanaka H; Fujiwara S; Miki T; Sagawa A; Nishizawa Y; Seino Y;
J Bone Miner Metab; 2005; 23(2):105-9. PubMed ID: 15750687
[No Abstract] [Full Text] [Related]
38. Alendronate: a new bisphosphonate for the treatment of osteoporosis.
Keen RW; Spector TD
Br J Clin Pract; 1996 Jun; 50(4):211-7. PubMed ID: 8759568
[TBL] [Abstract][Full Text] [Related]
39. Management of fibrous dysplasia. A report on 36 cases.
Saglik Y; Atalar H; Yildiz Y; Basarir K; Erekul S
Acta Orthop Belg; 2007 Feb; 73(1):96-101. PubMed ID: 17441665
[TBL] [Abstract][Full Text] [Related]
40. [Reduction of the Nordin index after therapy with oral alendronate in patients with postmenopausal osteoporosis].
Busi S; Catalano A
Clin Ter; 1995 Dec; 146(12):857-9. PubMed ID: 8681505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
